219 related articles for article (PubMed ID: 32777209)
1. A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis.
Zhu M; Yang H; Chen Z; Xia X; Deng Q; Shen Y
Exp Eye Res; 2020 Oct; 199():108180. PubMed ID: 32777209
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Miyazaki A; Kitaichi N; Ohgami K; Iwata D; Jin XH; Iwabuchi K; Morohashi T; Ohno S; Onoé K
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):747-57. PubMed ID: 18087711
[TBL] [Abstract][Full Text] [Related]
3. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
4. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.
Zheng C; Lei C; Chen Z; Zheng S; Yang H; Qiu Y; Lei B
Mol Vis; 2015; 21():403-11. PubMed ID: 25883526
[TBL] [Abstract][Full Text] [Related]
5. LY294002 attenuates inflammatory response in endotoxin-induced uveitis by downregulating JAK3 and inactivating the PI3K/Akt signaling.
Wu X; Pu L; Chen W; Zhao Q; Wu G; Li D; Zhu H
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):510-518. PubMed ID: 35344456
[TBL] [Abstract][Full Text] [Related]
6. Effects of the 24 N-terminal amino acids of p55PIK on endotoxinstimulated release of inflammatory cytokines by HaCaT cells.
Lv F; You W; Yu Y; Hu JB; Zhang B; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):587-593. PubMed ID: 23904382
[TBL] [Abstract][Full Text] [Related]
7. A cell-permeable peptide inhibitor of p55PIK signaling alleviates suture-induced corneal neovascularization and inflammation.
Huang J; Zhang Y; Lin T; Yin H; Pan Y; Zhu M; Zhang M
Heliyon; 2023 Apr; 9(4):e14869. PubMed ID: 37095989
[TBL] [Abstract][Full Text] [Related]
8. The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats.
Uchida T; Honjo M; Yamagishi R; Aihara M
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5584-5593. PubMed ID: 29084331
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats.
Lennikov A; Kitaichi N; Noda K; Ando R; Dong Z; Fukuhara J; Kinoshita S; Namba K; Mizutani M; Fujikawa T; Itai A; Ohno S; Ishida S
Mol Vis; 2012; 18():2586-97. PubMed ID: 23112571
[TBL] [Abstract][Full Text] [Related]
10. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.
Niu T; Cheng L; Wang H; Zhu S; Yang X; Liu K; Jin H; Xu X
J Neuroinflammation; 2019 Dec; 16(1):278. PubMed ID: 31883532
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
12. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
13. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 Suppresses Ocular Inflammation by Inhibiting the Activation of NF-κβ Pathway in Endotoxin-Induced Uveitis.
Tang W; Ma J; Gu R; Ding X; Lei B; Wang X; Zhuang H; Xu G
Cell Physiol Biochem; 2018; 46(1):375-388. PubMed ID: 29590655
[TBL] [Abstract][Full Text] [Related]
15. A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis.
Touchard E; Omri S; Naud MC; Berdugo M; Deloche C; Abadie C; Jonet L; Jeanny JC; Crisanti P; de Kozak Y; Combette JM; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4683-93. PubMed ID: 20393119
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.
Yadav UC; Shoeb M; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8076-85. PubMed ID: 21911582
[TBL] [Abstract][Full Text] [Related]
17. The Protective Effects of VVN001 on LPS-Induced Inflammatory Responses in Human RPE Cells and in a Mouse Model of EIU.
Qiu R; Yang M; Wang W; Liu J; Yang L; Lei B
Inflammation; 2021 Apr; 44(2):780-794. PubMed ID: 33200357
[TBL] [Abstract][Full Text] [Related]
18. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
19. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats.
Jin XH; Ohgami K; Shiratori K; Suzuki Y; Hirano T; Koyama Y; Yoshida K; Ilieva I; Iseki K; Ohno S
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2562-8. PubMed ID: 16723471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
